Galapagos NV (FRA:GXE) Scaled Net Operating Assets : -0.05 (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Galapagos NV Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Galapagos NV's operating assets for the quarter that ended in Dec. 2024 was €1,018.1 Mil. Galapagos NV's operating liabilities for the quarter that ended in Dec. 2024 was €1,227.1 Mil. Galapagos NV's Total Assets for the quarter that ended in Sep. 2024 was €4,172.2 Mil. Therefore, Galapagos NV's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was -0.05.

Galapagos NV Scaled Net Operating Assets Historical Data

The historical data trend for Galapagos NV's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Scaled Net Operating Assets Chart

Galapagos NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.41

-0.36

-0.30

-0.19

-0.05

Galapagos NV Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.20	-0.15	-0.12	-0.11	-0.05

Competitive Comparison of Galapagos NV's Scaled Net Operating Assets

For the Biotechnology subindustry, Galapagos NV's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galapagos NV's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Scaled Net Operating Assets falls into.

Galapagos NV Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Galapagos NV's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2024 )
=	(Operating Assets (A: Dec. 2024 )	-	Operating Liabilities (A: Dec. 2024 ))	/	Total Assets (A: Dec. 2023 )
=	(1018.146	-	1227.058)	/	4357.396
=	-0.05

where

	Operating Assets		(A: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4135.719	-	3117.573
=	1018.146

	Operating Liabilities		(A: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1238.78	-	8.243	-	3.479
=	1227.058

Galapagos NV's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Sep. 2024 )
=	(1018.146	-	1227.058)	/	4172.202
=	-0.05

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4135.719	-	3117.573
=	1018.146

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1238.78	-	8.243	-	3.479
=	1227.058

Galapagos NV Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (FRA:GXE) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

GLPGF:USA GLPG:USA GLPG:Netherlands GLPGa:UK 0JXZ:UK GXEA:Germany GXE:Germany GXEA:Germany G1LP34:Brazil GLPG:Austria

Address

Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800

Website

https://www.glpg.com

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Galapagos NV Headlines

No Headlines